The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 1040-1045

  Ritenour, Chad W M ^a,b   Abbott, John T ^a,b   Goodman, Michael ^c   Alazraki, Naomi ^b   Marshall, Fray F ^a,b   Issa, Muta M ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Bone scan; Gleason grade; Prostate; Prostate specific antigen; Prostatic neoplasm; Staging

Indexed keywords

MEDRONATE TECHNETIUM TC 99M; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROSTATE BIOPSY; PROSTATE CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ALGORITHMS; BONE AND BONES; BONE NEOPLASMS; DECISION MAKING; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 77649306575     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.113     Document Type: Article

References (23)

1. Albertson, P.C., Hanley, J.A., Harlan, L.C., Gilliland, F.D., Hamilton, A., Liff, J.M., Stanford, J.L., and Stephenson, R.A. (2000) The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis. J. Urol. 163, 1138-1143.
2. American Cancer Society (ACS) (2008) Cancer Facts and Figures 2008. American Cancer Society, Atlanta. (http://www.cancer.org/downloads/STT/ 2008CAFFfinalsecured.pdf accessed 07/06/2009)
3. Kindrick, A.V., Grossfeld, G.D., Stier, D.M., Flanders, S.C., Henning, J.M., and Carroll, P.R. (1998) Use of imaging tests for staging newly diagnosed prostate cancer: trends for CaPSURE database. J. Urol. 160, 2102-2106.
4. Cooperberg, M.R., Lubeck, D.P., Grossfeld, G.D., Mehta, S.S., and Carroll, P.R. (2002) Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor. J. Urol. 168, 491-495.
5. (1995) American Urological Association Prostate Cancer Clinical Guidelines Panel: Report on the Clinically Localized Prostate Cancer. Clinical Practice Guidelines.
6. McGregor, B., Tulloch, A.G., Quinlan, M.F., and Lovegrove, F. (1978) The role of bone scanning in the assessment of prostatic carcinoma. Br. J. Urol. 50, 178-181.
7. American Urological Association: Prostate-Specific Antigen - Best Practice Statement: 2009 Update. (http://www.auanet.org/content/guidelines-and- quality-care/clinical-guidelines/mainreports/psa09.pdf accessed 07/06/2009).
8. American College of Radiology (ACR) (2000) Staging Evaluation for Patients with Adenocarcinoma of the Prostate. ACR Appropriateness Criteria.
9. Abuzallouf, S., Dayes, I., and Lukka, H. (2004) Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J. Urol. 171, 2122-2127.
10. Partin, A.W., Kattan, M.W., Subong, E.N., Walsh, P.C., Wojno, K.J., Oesterling, J.E., Scardino, P.T., and Pearson, J.D. (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 277, 1445-1451.
11. National Center for Veterans Analysis and Statistics (NCVAS) (2009) (http://www1.va.gov/vetdata/docs/4X6-spring09-sharepoint.pdf accessed 07/06/2009).
12. Whitmore, W.J., Jr. (1984) Natural history and staging of prostate cancer. Urol. Clin. North Am. 11, 205-220.
13. Hur, J., Yoon, C.S., Ryu, Y.H., Yun, M.J., and Suh, J.S. (2007) Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy. J. Computer Assisted Tomogr. 31, 812-819.
14. Gomez, P., Manoharan, M., Kim, S.S., and Soloway, M.S. (2004) Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU Int. 94(3), 299-302.
15. Boyko, E., Koepsell, T., Gaziano, J., Horner, R.D., and Feussner, J.R. (2000) US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am. J. Epidemiol. 151(3), 307-314.
16. Oesterling, J.E., Martin, S.K., Bergstralh, E.J., and Lowe, F.C. (1993) The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 269, 57-60.
17. Rydh, A., Tomic, R., Tavelin, B., Hietala, S.O., and Damber, J.E. (1999) Predictive value of prostate-specific antigen, tumour stage and tumour grade for the outcome of bone scintigraphy in patients with newly diagnosed prostate cancer. Scand. J. Urol. Nephrol. 33, 89-93.
18. Fournier, G.R. and Narayan, P. (1993) Re-evaluation of the need for pelvic lymphadenectomy in low grade prostate cancer. Br. J. Urol. 72, 484-488.
19. Gleave, M.E., Coupland, D., Drachenberg, D., Cohen, L., Kwong, S., Goldenberg, S.L., and Sullivan, L.D. (1996) Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer. Urology 47, 708-712.
20. Haukaas, S., Roervik, J., Halvorsen, O.J., and Foelling, M. (1997) When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer? Br. J. Urol. 79, 770-776.
21. Bruwer, G., Heyns, C.F., and Allen, F.J. (1999) Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate. Eur. Urol. 35, 223-227.
22. O'Sullivan, J.M., Norman, A.R., Cook, G.J., Fisher, C., and Dearnaley, D.P. (2003) Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital. BJU Int. 92, 685-689.
23. Lee, N., Fawaaz, R., Olsson, C.A., Benson, M.C., Petrylak, D.P., Schiff, P.B., Bagiella, E., Singh, A., and Ennis, R.D. (2000) Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients. Int. J. Radiat. Oncol. Biol. Phys. 48, 1443-1446.